Matrubials
Davis
About Matrubials
Matrubials is developing novel antibacterial therapeutics to address non-selectivity and emerging antimicrobial resistance. They provide safe solutions that can reduce the healthcare and economic burden resulting from bacterial infections and concomitant clinical complications. That develops the anti-pathogenic molecules from milk into therapeutics geared towards all-age diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $130.0K
- Funding stage: Seed
- Last round: Grant (May 2023)
- Website: matrubials.com
Industries & Categories
Biotechnology, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/matrubials-41171 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.